Connecting aging biology and inflammation in the omics era
Open accessThe DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index; 134 of the 214 sources its claims cite were checked for support.
Abstract
Aging is characterized by the accumulation of damage to macromolecules and cell architecture that triggers a proinflammatory state in blood and solid tissues, termed inflammaging. Inflammaging has been implicated in the pathogenesis of many age-associated chronic diseases as well as loss of physical and cognitive function. The search for mechanisms that underlie inflammaging focused initially on the hallmarks of aging, but it is rapidly expanding in multiple directions. Here, we discuss the threads connecting cellular senescence and mitochondrial dysfunction to impaired mitophagy and DNA damage, which may act as a hub for inflammaging. We explore the emerging multi-omics efforts that aspire to define the complexity of inflammaging - and identify molecular signatures and novel targets for interventions aimed at counteracting excessive inflammation and its deleterious consequences while preserving the physiological immune response. Finally, we review the emerging evidence that inflammation is involved in brain aging and neurodegenerative diseases. Our goal is to broaden the research agenda for inflammaging with an eye on new therapeutic opportunities.
Overview
CoChat Summary
TL;DR
This review argues that inflammaging arises from intertwined aging hallmarks—cellular senescence, mitochondrial dysfunction, impaired mitophagy, and DNA damage—and can be dissected with multi-omics approaches. It surveys evidence linking these processes to age-related disease and brain aging, while highlighting unresolved questions about biomarkers, causality, and therapeutic targeting.
Key findings
- Cellular senescence and the SASP are presented as key drivers of local and systemic inflammation, contributing to conditions such as atherosclerosis, osteoarthritis, cancer, pulmonary fibrosis, Alzheimer’s disease, Parkinson’s disease, and insulin resistance; senescent immune cells may also drive aging of solid organs.
- Mitochondrial dysfunction is described as a nexus linking impaired mitophagy, DNA damage, NAD+ depletion, and inflammatory pathways including NLRP3, cGAS/STING, and NF-κB; DNA of mammalian cells experiences over 10^5 modifications per day, many ROS-related single-strand breaks.
- Multi-omics studies are beginning to resolve inflammation subtypes: a PCA of 19 proteins identified two immune-signaling components, and an inflammatory age score derived from 73 plasma and CSF proteins accounted for approximately 40% of the variance in chronological age and was associated with AD dementia, AD pathology, and lower cognition.
- Genetic contributions to immune traits vary widely: one large-scale GWAS found a median heritability of 37% for a broad set of immune cell types and traits, with some phenotypes as high as 96%; serum cytokine/chemokine heritability ranges from 50% to 90% in healthy twins aged 8–82 years, and TNF-α variance explained by genome-wide SNP data was more than 70% after fungal stimulation and more than 50% after LPS stimulation.
Methods
- Narrative review; no primary experimental design, sample, or statistical analysis is reported.
- Synthesizes evidence from animal models, human cohort studies, clinical trials, multi-omics/proteomic platforms, single-cell RNA sequencing, and genetic studies.
- Thematically organized around cellular senescence/SASP, age-related mitochondrial dysfunction, multi-omics approaches to inflammaging, and inflammation in brain aging and neurodegenerative disease.
Limitations
- The paper states that the robustness and generalizability of developed inflammatory signatures are not ready for clinical applications; that a causal role for cellular senescence in neurodegenerative disease has yet to be established; that the extent to which neuroinflammation is protective or pathogenic is unknown; and that attempts to distinguish beneficial from pathological senescence at proteome, transcriptome, and functional levels have not been successful.
- The paper also notes limitations of current large-scale proteomic approaches, including platform-specific measurement variation, incomplete target validation, a bias toward secreted proteins, and limited breadth of protein measurement.
- Evident from the text: this is a narrative review without a systematic search strategy or meta-analysis, and its topic selection is explicitly focused on a few areas rather than being exhaustive.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
77 Valid · 2 Not valid · 47 Not checked · 25 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Aging is characterized by the accumulation of damage to macromolecules and cell architecture that triggers a proinflammatory state in blood and solid tissues, termed inflammaging.”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Partly supportedcites [1] Ferrucci, 2020, Measuring biological aging in humans: a quest, Aging Cell sourceExperimental — accuracy not yet measured
The closest body statement (CONNECTING THE BIOLOGY OF AGING WITH AGE‐ASSOCIATED MULTIMORBIDITY) says the hallmarks of aging 'directly or indirectly cause an inflammatory state, suggesting that the pro‐inflammatory state observed in many older persons may reflect the burden of biological aging' — i.e. a hedged inference credited to Ferrucci et al. 2005, Franceschi & Campisi 2014 and Fulop et al. 2018, not the assertive causal statement of the claim. The damage half is supported (INTRODUCTION/Figure 1: 'Over time, damage accumulates that is not fully compensated by resilience'; Proteostasis: 'repair, recycling, and elimination of damaged macromolecules/organelles… maintaining cell integrity'), and blood-side inflammation is covered via circulating IL‑6 and SASP proteins spilling over from tissues, but our copy nowhere defines this state as 'inflammaging' — the word occurs only inside reference titles (refs 75, 79, 82). So the label 'termed inflammaging' and the flat causal phrasing are not supported by this paper. (LLM, conf=0.72)
- Partly supportedcites [2] sourceExperimental — accuracy not yet measured
Ferrucci et al.'s 'Time and the Metrics of Aging' (Hallmarks or Pillars of Aging as Drivers of Age-Related Diseases) does treat inflammation as downstream of other aging mechanisms and a strong risk factor for cardiovascular disease and multi-morbidity, and the Temporal Hierarchy / Building Connections sections describe accumulating molecular and cellular damage (misfolded proteins, damaged mitochondria, DNA damage) outpacing resilience mechanisms — so the damage-accumulation half of the claim is in our copy. However, the causal chain is framed as a hypothesis ('The hypothesis of a common mechanism is consistent with inflammation being a "pillar" that is downstream of other mechanisms of aging'), not as the stated characterization of aging the citing sentence asserts, and our copy never uses the term 'inflammaging' nor describes a proinflammatory state specifically 'in blood and solid tissues' (the only tissue-inflammation passage attributes inflammatory cytokine production to senescent cells and notes it derives largely from animal models, untranslato to humans). The unsupported parts are the definitive causal wording, the 'blood and solid tissues' specification, and the coinage/attribution of the label 'inflammaging' to this paper. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“With aging, resilience mechanisms become less effective at repairing or removing damage and preventing its deleterious effects on health (2).”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Supportedcites [2] source
The section 'Building Connections Between the Metrics of Aging' (p. of passage 1) states directly that resilience mechanisms perform maintenance and repair and that 'their efficiency eventually fades and allows entropy to result in frailty and death.' 'The Temporal Hierarchy of the Metrics of Aging' (passage 2) reinforces this by listing repair/removal processes (chaperone refolding, autophagy, mitophagy, DNA repair, senescence/apoptosis, stem-cell replacement) and noting that when accumulating damage overcomes these compensatory mechanisms, effects on phenotype become progressively evident, i.e., deleterious health effects. The Summary (passage 8) adds that functional aging occurs only when resilience mechanisms are exhausted. The paraphrase matches the source in content and qualifiers. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although increased levels of inflammatory mediators (mostly IL-1, IL-6, TNF-α, and its receptors) are detected in all elderly individuals, higher levels of these biomarkers are associated with increased risk for many chronic conditions, including dementia, disability, and physical frailty.”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Partly supportedcites [4] sourceExperimental — accuracy not yet measured
The ‘Risk factors and causes of inflammageing’ section lists IL-1, IL-6, TNF and soluble TNF receptors among age-associated inflammatory markers, but says high levels are detected in the majority of older individuals, not all. The ‘Inflammation and age-related frailty’ section also links inflammation to dementia, disability and features of frailty. Page numbers are not provided in our copy’s passages. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hallmarks of immune aging are (a) a state of proinflammatory activation characterized by high circulating levels of proinflammatory cytokines — such as IL-6 and TNF-α — and localized tissue inflammation”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Supportedcites [6] source
The 'COVID-19 and inflammaging' section states that dysfunction of the hallmarks of aging converges into a pro-inflammatory response and that inflammaging 'is characterized clinically by higher levels of several inflammatory blood biomarkers, including CRP, IL-6, IL-18, and TNF', i.e. the elevated circulating IL-6/TNF part of the claim. The tissue component is covered by the same sections and Fig. 1/Fig. 2 captions, which describe accumulation of senescent cells in various tissues secreting SASP pro-inflammatory cytokines that spill into the circulation, and by 'COVID-19 and mechanisms of inflammaging in older individuals', which describes the aging immune system as maintaining 'a permanent state of mild activation' combined with a chronic pro-inflammatory state (immunosenescence). The citing sentence's label 'hallmarks of immune aging' is the authors' framing; the paper speaks of hallmarks of aging/inflammaging, but the attributed content matches. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The immune system undergoes numerous and profound changes with aging, which are extensively reviewed elsewhere (3–5).”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Supportedcites [3] source
The Introduction (p. 5) describes age-related chronic activation of the innate immune system and several cellular and molecular mechanisms involved in inflammaging. This supports the broad claim that the immune system changes substantially with age. (LLM, conf=0.87)
- Supportedcites [4] source
The ‘Risk factors and causes of inflammageing’ section states that ageing is associated with immune dysregulation and describes changes in inflammatory markers. Its subsections on intrinsic immune-cell defects and cellular senescence describe further age-related changes in lymphocytes, supporting the broad claim. (LLM, conf=0.90)
- Supportedcites [5] source
The section “Chronic inflammation and the immune response to acute challenges” (page not provided) describes several age-related immune changes: increasing systemic chronic inflammation, reduced components of the immune response, greater susceptibility to viral infection, and weaker vaccine responses. These support the citing sentence’s broad statement that the immune system changes substantially with aging. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
87 more claims · 60 with their cited sources checked
Create a free account to see all 151 claims and to verify the 80 references still open.
- It may state two separate claims as one. 55
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the ML-defined senescent populations were enriched for other senescence signatures,12–18 although with some lineage-specific disparities for some lists (Figure 4G)”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [13]
Experimental — accuracy not yet measured
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 1×
“1172/JCI158448 Efforts to characterize inflammation in humans have relied on one or a few inflammatory proteins, with IL-6, TNF-α, and CRP being the most widely used (5).”
BackgroundSelf-citationAutophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Self-citationInflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 1×
“Cellular senescence can be initiated by multiple intrinsic and extrinsic nonlethal stresses, including genotoxic, oncogenic, mitochondrial, oxidative, inflammatory, paracrine signaling, and others (11).”
BackgroundGenomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Gillet, L. C., Navarro, P., Tate, S., Röst, H., Selevsek, N., Reiter, L., Bonner, R., & Aebersold, R. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o111.016717 · Cited by 2,877
Cited by
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Chronic inflammation and the hallmarks of aging
Baechle, J. J., Chen, N., Makhijani, P., Winer, S., Furman, D., & Winer, D. A. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101755 · Cited by 471
SenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
“Other potential sources of circulating biomarkers remain to be explored in detail in vivo, including senescence-associated extracellular vesicles (another bioactive component of the SASP 290 ) and senescent circulating lymphocytes 86,290–294 .”
Self-citationSingh, A., Schurman, S. H., Bektas, A., Kaileh, M., Roy, R., Wilson, D. M., Sen, R., & Ferrucci, L. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041197 · Cited by 182
Self-citationCembrowska-Lech, D., Krzemińska, A., Miller, T., Nowakowska, A., Adamski, C., Radaczyńska, M., Mikiciuk, G., & Mikiciuk, M. (2023) · Biology · doi:10.3390/biology12101298 · Cited by 175
Metadata
- Authors
- Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L.
- Affiliations
- National Institutes of Health (US)
- Hasselt University (BE)
- Corresponding author
- Ferrucci, Luigi
- Venue
- Journal of Clinical Investigation
- Published
- 2022-07-15
- Volume
- 132
- Issue
- 14
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC9282936
- OpenAlex
- W4285385649
- Cited by
- 189
- References
- 189
- Citations by year
- 2026: 39 · 2025: 61 · 2024: 47 · 2023: 36 · 2022: 6
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Document Server@UHasselt (UHasselt) (submittedVersion, other-oa)
- Funders
- Office of Dietary Supplements
- National Institutes of Health
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- inflammaging, aging, cellular senescence, mitochondrial dysfunction, mitophagy, DNA damage, hallmarks of aging, multi-omics, brain aging, neurodegenerative diseases, anti-inflammatory therapy
- MeSH terms
- Aging, Biology, DNA Damage, Humans, Inflammation, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Connecting aging biology and inflammation in the omics era. https://app.cochat.ai/papers/10.1172/jci158448
- The paper
- Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022). Connecting aging biology and inflammation in the omics era. Journal of Clinical Investigation. https://doi.org/10.1172/jci158448
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.